Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment.
作者信息
Hirawat S, Lichtman S M, Allen S L
机构信息
Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital-New York University School of Medicine, Manhasset, New York 11030, USA.
出版信息
Am J Hematol. 2001 Mar;66(3):224-6. doi: 10.1002/1096-8652(200103)66:3<224::aid-ajh1049>3.0.co;2-e.
Abstract
Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion.
摘要
Zotero 插件